RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION (USD $) | 3 Months Ended | 6 Months Ended |
In Thousands, except Per Share data, unless otherwise specified | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 |
Total revenue | $11,754 | | $11,039 | | $22,717 | | $21,197 | |
Total cost of revenue | 1,450 | | 1,391 | | 2,953 | | 2,717 | |
Gross profit | 10,304 | | 9,648 | | 19,764 | | 18,480 | |
Research and development expenses | 1,871 | | 1,758 | | 3,786 | | 3,486 | |
Selling, general and administrative expenses | 6,761 | | 6,477 | | 13,235 | | 12,803 | |
Non-cash amortization of acquired intangible assets | ' | | ' | | ' | | ' | |
Stock-based compensation | ' | | ' | | ' | | ' | |
Operating income | 1,672 | | 1,413 | | 2,743 | | 2,191 | |
Financial income (expenses), net | 35 | | -40 | | -4 | | -24 | |
Taxes on income | -409 | | -377 | | -759 | | -569 | |
Other | -5 | | 3 | | -26 | | 5 | |
Net income | 1,293 | | 999 | | 1,954 | | 1,603 | |
Less: Net (income) loss attributable to the noncontrolling interest | ' | | 3 | | -10 | | 3 | |
Net income attributable to Cimatron's shareholders | 1,293 | | 1,002 | | 1,944 | | 1,606 | |
Net income per share - basic and diluted | $0.12 | | $0.11 | | $0.18 | | $0.17 | |
Weighted average number of shares outstanding | ' | | ' | | ' | | ' | |
Basic EPS (in thousands) | 10,751 | | 9,362 | | 10,741 | | 9,355 | |
Diluted EPS (in thousands) | 10,761 | | 9,362 | | 10,744 | | 9,360 | |
Adjustment [Member] | ' | | ' | | ' | | ' | |
Total revenue | ' | | ' | | ' | | ' | |
Total cost of revenue | -147 | [1] | -147 | [1] | -294 | [1] | -294 | [1] |
Gross profit | 147 | | 147 | | 294 | | 294 | |
Research and development expenses | -12 | [2] | ' | [2] | -24 | [2] | ' | [2] |
Selling, general and administrative expenses | ' | | ' | | ' | | ' | |
Non-cash amortization of acquired intangible assets | ' | | -32 | | ' | | -85 | |
Stock-based compensation | -147 | | ' | | -284 | | ' | |
Operating income | 306 | | 179 | | 602 | | 379 | |
Financial income (expenses), net | ' | | ' | | ' | | ' | |
Taxes on income | -85 | [3] | ' | [3] | -168 | [3] | -91 | [3] |
Other | ' | | ' | | ' | | ' | |
Net income | 221 | | 179 | | 434 | | 288 | |
Less: Net (income) loss attributable to the noncontrolling interest | ' | | ' | | ' | | ' | |
Net income attributable to Cimatron's shareholders | 221 | | 179 | | 434 | | 288 | |
Non-GAAP [Member] | ' | | ' | | ' | | ' | |
Total revenue | 11,754 | | 11,039 | | 22,717 | | 21,197 | |
Total cost of revenue | 1,303 | | 1,244 | | 2,659 | | 2,423 | |
Gross profit | 10,451 | | 9,795 | | 20,058 | | 18,774 | |
Research and development expenses | 1,859 | | 1,758 | | 3,762 | | 3,486 | |
Selling, general and administrative expenses | 6,614 | | 6,445 | | 12,951 | | 12,718 | |
Non-cash amortization of acquired intangible assets | ' | | ' | | ' | | ' | |
Stock-based compensation | ' | | ' | | ' | | ' | |
Operating income | 1,978 | | 1,592 | | 3,345 | | 2,570 | |
Financial income (expenses), net | 35 | | -40 | | -4 | | -24 | |
Taxes on income | -494 | | -377 | | -927 | | -660 | |
Other | -5 | | 3 | | -26 | | 5 | |
Net income | 1,514 | | 1,178 | | 2,388 | | 1,891 | |
Less: Net (income) loss attributable to the noncontrolling interest | ' | | 3 | | -10 | | 3 | |
Net income attributable to Cimatron's shareholders | $1,514 | | $1,181 | | $2,378 | | $1,894 | |
Net income per share - basic and diluted | $0.14 | | $0.13 | | $0.22 | | $0.20 | |
Weighted average number of shares outstanding | ' | | ' | | ' | | ' | |
Basic EPS (in thousands) | 10,751 | | 9,362 | | 10,741 | | 9,355 | |
Diluted EPS (in thousands) | 10,761 | | 9,362 | | 10,744 | | 9,360 | |
|
[1] | Non-GAAP adjustment to exclude non-cash amortization of acquired intangible assets |
[2] | Non-GAAP adjustment to exclude stock-based compensation |
[3] | Non-GAAP adjustment to exclude the effect of deferred taxes and other non-current tax provisions. |